Annual Cash & Cash Equivalents
$2.96 M
+$1.40 M+89.24%
June 1, 2024
Summary
- As of February 8, 2025, RGC annual cash & cash equivalents is $2.96 million, with the most recent change of +$1.40 million (+89.24%) on June 1, 2024.
- During the last 3 years, RGC annual cash & cash equivalents has risen by +$2.90 million (+4885.19%).
- RGC annual cash & cash equivalents is now -53.85% below its all-time high of $6.42 million, reached on June 30, 2022.
Performance
RGC Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.96 M
NaN%
June 1, 2024
Summary
- As of February 8, 2025, RGC quarterly cash and cash equivalents is $2.96 million
- Over the past year, RGC quarterly cash and cash equivalents has increased by +$1.40 million (+89.24%).
- RGC quarterly cash and cash equivalents is now -53.85% below its all-time high of $6.42 million, reached on June 30, 2022.
Performance
RGC Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RGC Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.2% | +89.2% |
| 3 y3 years | +4885.2% | +4885.2% |
| 5 y5 years | +1117.1% | +665.2% |
RGC Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.9% | +4885.2% | -53.9% | +89.2% |
| 5 y | 5-year | -53.9% | +4885.2% | -53.9% | +4885.2% |
| alltime | all time | -53.9% | +4885.2% | -53.9% | +4885.2% |
Regencell Bioscience Holdings Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | $2.96 M(+89.2%) | $2.96 M(+89.2%) |
| Jun 2023 | $1.56 M(-75.6%) | $1.56 M(-75.6%) |
| Jun 2022 | $6.42 M(>+9900.0%) | $6.42 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | $59.40 K(-84.7%) | $59.40 K(-80.6%) |
| Dec 2020 | - | $306.00 K(-20.9%) |
| Jun 2020 | $387.00 K(+59.1%) | $387.00 K |
| Jun 2019 | $243.30 K | - |
FAQ
- What is Regencell Bioscience Holdings Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Regencell Bioscience Holdings Limited?
- What is Regencell Bioscience Holdings Limited annual cash & cash equivalents year-on-year change?
- What is Regencell Bioscience Holdings Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Regencell Bioscience Holdings Limited?
- What is Regencell Bioscience Holdings Limited quarterly cash and cash equivalents year-on-year change?
What is Regencell Bioscience Holdings Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of RGC is $2.96 M
What is the all time high annual cash & cash equivalents for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high annual cash & cash equivalents is $6.42 M
What is Regencell Bioscience Holdings Limited annual cash & cash equivalents year-on-year change?
Over the past year, RGC annual cash & cash equivalents has changed by +$1.40 M (+89.24%)
What is Regencell Bioscience Holdings Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RGC is $2.96 M
What is the all time high quarterly cash and cash equivalents for Regencell Bioscience Holdings Limited?
Regencell Bioscience Holdings Limited all-time high quarterly cash and cash equivalents is $6.42 M
What is Regencell Bioscience Holdings Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, RGC quarterly cash and cash equivalents has changed by +$1.40 M (+89.24%)